Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Vanja Cabric et al.|Journal of Clinical Oncology|2016Cited by 867
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Adam Shlien, Mehdi Layeghifard et al.|Nature Communications|2023Cited by 46
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J. Duchatel, David M. Ashley, Evangeline R. Jackson et al.|Journal of Clinical Investigation|2024Cited by 44
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Kuo-Sheng Wu, Palma Solano‐Páez et al.|The Lancet Child & Adolescent Health|2021Cited by 41